COVID-19 immune response appears strong in cancer patients
(HealthDay)—The seropositivity rate among patients with cancer remains high four months after the second dose of the COVID-19 vaccine, according to a research letter published online Aug. 11 in JAMA Oncology.
Aug 23, 2021
0
2